2025 NETRF Accelerator Award
The Neuroendocrine Tumor Research Foundation (NETRF) Accelerator Award provides $800,000 USD over four years to support transformative research that significantly advances the understanding, detection, or treatment of neuroendocrine tumors (NETs). The award targets high-risk, high-reward projects that are aligned with NETRF’s 2024 Research Roadmap, focusing on early detection, novel therapies, and precision oncology.
Eligibility:
-
Applicants must hold an MD, PhD, MD/PhD, or equivalent degree.
-
Must be faculty-level (Assistant Professor or higher).
-
Research must be conducted at a non-profit academic or research institution.
-
Open to international applicants.
-
Applicants from for-profit entities (e.g., biotech or pharma) are not eligible.
-
Only one proposal per Principal Investigator.
-
Projects must be distinct from existing funded work.
Funding:
-
800,000 USD total over 4 years ($200,000/year).
-
Indirect costs up to 10% included in the total award.
-
Funds may be used for PI salary (up to NIH cap), staff salaries, supplies, equipment, and research-related services.
-
Attendance at the NETRF Annual Research Symposium is required.
Deadline:
-
Full applications (by invitation): June 23, 2025, 5:00 p.m. ET
-
Awards announced: October/November 2025
-
Project start date: January 2026
More Information:
Applications must be submitted via ProposalCentral. For full details and instructions, visit:
https://netrf.org/research/grants/
Questions? Contact Anna Greene, PhD at [email protected]
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023